Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.35 - $0.72 $107,589 - $221,327
-307,399 Reduced 20.75%
1,173,800 $430,000
Q4 2022

Feb 13, 2023

SELL
$0.32 - $0.52 $44,364 - $72,091
-138,638 Reduced 8.56%
1,481,199 $585,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $0.76 $310,391 - $512,820
-674,764 Reduced 29.41%
1,619,837 $760,000
Q2 2022

Aug 12, 2022

SELL
$0.58 - $1.13 $89,609 - $174,583
-154,499 Reduced 6.31%
2,294,601 $1.34 Million
Q1 2022

May 13, 2022

BUY
$0.73 - $1.81 $917,223 - $2.27 Million
1,256,470 Added 105.35%
2,449,100 $2.47 Million
Q4 2021

Feb 11, 2022

BUY
$1.66 - $2.64 $1.17 Million - $1.86 Million
705,230 Added 144.69%
1,192,630 $1.98 Million
Q3 2021

Nov 12, 2021

BUY
$2.58 - $3.36 $1.22 Million - $1.59 Million
472,200 Added 3106.58%
487,400 $1.31 Million
Q2 2021

Aug 13, 2021

SELL
$2.7 - $3.81 $2.12 Million - $2.99 Million
-785,200 Reduced 98.1%
15,200 $50,000
Q1 2021

May 13, 2021

BUY
$3.02 - $5.16 $1.98 Million - $3.38 Million
655,700 Added 453.14%
800,400 $2.66 Million
Q4 2020

Feb 10, 2021

SELL
$2.66 - $4.18 $595,765 - $936,202
-223,972 Reduced 60.75%
144,700 $548,000
Q3 2020

Nov 13, 2020

SELL
$3.01 - $3.88 $1.17 Million - $1.5 Million
-387,700 Reduced 51.26%
368,672 $1.16 Million
Q2 2020

Aug 13, 2020

SELL
$2.33 - $4.6 $162,401 - $320,620
-69,700 Reduced 8.44%
756,372 $2.41 Million
Q1 2020

May 14, 2020

BUY
$1.91 - $4.52 $112,881 - $267,132
59,100 Added 7.71%
826,072 $2.21 Million
Q4 2019

Feb 13, 2020

BUY
$2.57 - $4.08 $165,765 - $263,160
64,500 Added 9.18%
766,972 $3.13 Million
Q3 2019

Nov 13, 2019

BUY
$2.74 - $4.65 $442,288 - $750,598
161,419 Added 29.83%
702,472 $2.29 Million
Q2 2019

Aug 12, 2019

BUY
$2.66 - $6.28 $1.2 Million - $2.83 Million
449,853 Added 493.26%
541,053 $1.99 Million
Q1 2019

May 14, 2019

BUY
$2.95 - $5.61 $163,135 - $310,233
55,300 Added 154.04%
91,200 $311,000
Q4 2018

Feb 13, 2019

BUY
$2.3 - $5.78 $82,570 - $207,502
35,900 New
35,900 $106,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $46.3M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.